Jónsdóttir, Freyja;
Blöndal, Anna B;
Guðmundsson, Aðalsteinn;
Bates, Ian;
Stevenson, Jennifer M;
Sigurðsson, Martin I;
(2024)
Potentially inappropriate medication use before and after admission to internal medicine for older patients and polypharmacy.
The American Journal of Medicine
10.1016/j.amjmed.2024.07.026.
(In press).
Text
1-s2.0-S0002934324004753-main.pdf - Accepted Version Access restricted to UCL open access staff until 5 February 2025. Download (953kB) |
Abstract
Background: With the aging of the population and the increase in chronic diseases, there is an inherent risk of polypharmacy and inappropriate medication use. The study aimed to determine the prevalence and incidence of potentially inappropriate medication use and its correlation with polypharmacy. Methods: A retrospective, population-based cohort study among patients ≥65 years hospitalized at The National University Hospital of Iceland from 2010-2020. Data on medication usage were retrieved from the National Prescription Medicine Registry. Based on the number of medications filled in in the year prior to admission and post-discharge, participants were categorized non-polypharmacy (<5), polypharmacy (5-9), and hyper-polypharmacy (≥10). The prevalence and incidence of potentially inappropriate medication use was assessed based on the 2019 Beers criteria. Regression models were used to correlate sociodemographic, clinical, and pharmacoepidemiologic variables and the odds of new potentially inappropriate medication use. Results: The cohort comprised 55,859 patients (48.5% male) with a median [IQR] age of 80 [73-86] years. The prevalence of inappropriate medication use in the year preceding admission was 34.0%, 77.7%, and 96.4% for patients with non-polypharmacy, polypharmacy, and hyper-polypharmacy. The incidence of new potentially inappropriate medication use was 46.7% (95% CI 45.6%-47.6%) among those with no potentially inappropriate medication use pre-admission. Factors associated with higher odds of new potentially inappropriate medication use after discharge were the use of multi-dose dispensing services, dementia, polypharmacy, and hyper-polypharmacy. Conclusions and Relevance: An increased emphasis is needed to review and reevaluate the appropriateness of medication use among older population in internal medicine. Clinical trial registration: https://clinicaltrials.gov/ct2/show/NCT05756400
Archive Staff Only
View Item |